Direct Pathogen Nucleic Acid Amplification Using Surfactant Master Mix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for viral and bacterial pathogens, such as RT-PCR, are time-consuming and expensive, requiring complex sample preparation and nucleic acid extraction steps, which hinder rapid and cost-effective detection.
Innovation Solution
A reagent mixture comprising a cationic surfactant and buffer, including components like KCl and bovine serum albumin, allows for direct amplification of nucleic acids without prior extraction, utilizing thermocycling and DNA polymerase to amplify target nucleic acids in biological samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If RT-PCR is used for viral detection, then sensitivity and specificity are improved, but time consumption and cost increase
Solution Approach 1:
The patent combines reverse transcription and PCR amplification into a single one-step reaction, eliminating the need for separate RNA extraction and cDNA synthesis steps. This merging of multiple operations into one integrated process reduces time consumption while maintaining the high sensitivity and specificity of RT-PCR detection.
Solution Approach 2:
The patent incorporates all necessary reagents (reverse transcriptase, DNA polymerase, primers, buffers) into a pre-prepared master mix that can directly process clinical samples. This preliminary preparation eliminates the need for time-consuming nucleic acid extraction steps, allowing direct amplification from raw samples while preserving detection accuracy.
2Measurement precision
If nucleic acid extraction is performed prior to PCR, then detection accuracy is improved, but process complexity and cost increase
Solution Approach 1:
The patent selectively extracts and removes inhibitory substances from clinical samples through optimized buffer composition and reaction conditions, while retaining the target nucleic acids for amplification. This selective extraction approach eliminates the need for complex purification protocols, reducing process complexity while maintaining sufficient detection accuracy by removing only harmful interference.
Solution Approach 2:
The one-step RT-PCR system is designed to be self-sufficient by incorporating all necessary enzymes, buffers, and reagents into a single master mix that can directly process clinical samples without external purification steps. The system performs both reverse transcription and PCR amplification in one reaction vessel, eliminating the need for separate extraction equipment and procedures.
3Ease of operation
If standard PCR is used for bacterial detection, then procedure simplicity is improved, but detection sensitivity and speed worsen
Solution Approach 1:
The patent incorporates a preliminary thermal lysis step that directly breaks open bacterial cells and releases genomic DNA into the reaction mixture before amplification begins. This pre-processing action eliminates the need for separate cell lysis and nucleic acid extraction steps, maintaining procedural simplicity while significantly reducing total detection time by preparing the template in advance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and sensitive detection of pathogens like influenza and C. difficile directly from samples, reducing the need for extraction and purification steps while maintaining or improving sensitivity compared to traditional methods.
Implementation Method 1
a reagent mixture comprising a cationic surfactant and buffer, including components like KCl and bovine serum albumin, allows for direct amplification of nucleic acids without prior extraction
Implementation Method 2
utilizing thermocycling and DNA polymerase to amplify target nucleic acids in biological samples
Data Source
Figure 1A
Figure 1B
Figure 2A
AI summary
Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.